A detailed history of Capital Management Associates, Inc transactions in Glaukos Corp stock. As of the latest transaction made, Capital Management Associates, Inc holds 2,204 shares of GKOS stock, worth $207,727. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,204
Holding current value
$207,727
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025

BUY
$96.6 - $161.22 $212,906 - $355,328
2,204 New
2,204 $217 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.49B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Capital Management Associates, Inc Portfolio

Follow Capital Management Associates, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Management Associates, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Management Associates, Inc with notifications on news.